Avadel pharmaceuticals to present at upcoming investor conferences

Dublin, ireland, march 22, 2022 (globe newswire) -- avadel pharmaceuticals plc (nasdaq: avdl), a company focused on transforming medicines to transform lives, announced today that greg divis, chief executive officer of avadel, will participate in the following upcoming investor conferences:

AVDL Ratings Summary

AVDL Quant Ranking